How does our body detect and destroy foreign invaders? Why does the body attack itself in diseases such as diabetes? And what is cancer immunotherapy? This and other questions are answered in a new animation released today by the Davis and Cornall groups, the two labs worked together with Oxford Sparks aimed at school students to introduce the main players of the immune system and some of the latest research in fighting diseases such as cancer.
The APPG on Malaria & NTDs gathered on Tuesday, March 19th in Westminster at the Houses of Parliament. Jeremy Lefroy MP welcomed Rob van der Pluijm on behalf of the Mahidol-Oxford Tropical Medicine Research Unit (MORU), the Tracking Resistance to Artemesinin Collaboration II and the Developing Triple Artemisinin-based Combination Therapies (DeTACT) Project.
The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) has been awarded £4.5 million to accelerate clinical research to prevent illness and deaths from epidemic infectious diseases. ISARIC is a world-wide, grass-roots consortium of clinical research networks, working together on epidemic infections such as pandemic influenza, Ebola, Lassa fever, and plague.
A new Cancer Research grant will help them develop early detection methods for one of the leading causes of cancer death in the UK. Deborah Goberdhan and Elizabeth Bird-Lieberman from the Translational Gastroenterology Unit of the Experimental Medicine Division, John Radcliffe Hospital, have been awarded a Cancer Research UK Primer grant of £100,000 to study ‘Serum extracellular vesicle signatures as biomarkers for non-invasive early detection of oesophageal adencarcinoma’
Centre PI, Prof Peter Donnelly, was part of the Royal Society "You and AI" panel discussion. You can watch the entire event, chaired by Brian Cox, online.
Director of Wellcome since 2013, Jeremy Farrar was previously Director of our OUCRU Vietnam programme for 18 years. He has published almost 600 peer-reviewed scientific papers, and mentored many dozens of students and fellows. These honours recognise the outstanding commitment and contribution Jeremy has made to science and medicine, and to improving health for individuals and communities globally.
It is with great sadness that we learnt of the death of Sir David Weatherall this weekend. Sir David Weatherall, fondly called ‘Prof’ by those who knew him, was a general physician, a haematologist and clinician scientist whose research focused on the genetics of blood disorders affecting haemoglobin, such as thalassaemia and sickle cell disease. As Nuffield Professor of Medicine, David inspired several generations of clinicians and scientists to investigate the molecular basis of human diseases and apply this knowledge to improve human health.
The UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC), announced by Business Secretary Greg Clark MP, represents a major commercial opportunity and also a new front line in the nation’s defence against global pandemic threats. Led by the Jenner Institute, the new centre has been awarded funding by UK Research and Innovation of £66 million through the UK Government’s Industrial Strategy Challenge Fund (ISCF) Medicines Manufacturing challenge.
If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.